PTC-028
99%
- Product Code: 102170
CAS:
1782970-28-8
| Molecular Weight: | 405.32 g./mol | Molecular Formula: | C₁₉H₁₂F₅N₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD28716152 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
PTC-028 is primarily investigated for its potential in cancer therapy, particularly in targeting and inhibiting specific pathways involved in tumor growth and survival. It is being studied for its ability to modulate key proteins that regulate cell proliferation and apoptosis, making it a promising candidate for treating various types of cancers. Researchers are exploring its efficacy in preclinical models to determine its potential as a targeted therapeutic agent, especially in cancers that are resistant to conventional treatments. Additionally, PTC-028 is being evaluated for its pharmacokinetic properties and safety profile to assess its suitability for clinical trials. Its role in overcoming drug resistance in cancer cells is a significant focus, offering hope for improved treatment outcomes in challenging cases.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $419.89 |
+
-
|
| 0.025 | 10-20 days | $1,346.06 |
+
-
|
PTC-028
PTC-028 is primarily investigated for its potential in cancer therapy, particularly in targeting and inhibiting specific pathways involved in tumor growth and survival. It is being studied for its ability to modulate key proteins that regulate cell proliferation and apoptosis, making it a promising candidate for treating various types of cancers. Researchers are exploring its efficacy in preclinical models to determine its potential as a targeted therapeutic agent, especially in cancers that are resistant to conventional treatments. Additionally, PTC-028 is being evaluated for its pharmacokinetic properties and safety profile to assess its suitability for clinical trials. Its role in overcoming drug resistance in cancer cells is a significant focus, offering hope for improved treatment outcomes in challenging cases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :